个人中心 - 老虎社区

股海蓝天

IP属地：未知

帖子 · 4帖子 · 4
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 股海蓝天股海蓝天
  ·2025-12-04
  $MIRXES-B(02629)$ 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。
  369 评论
  1
  分享
  举报
- 股海蓝天股海蓝天
  ·2025-09-25
  医疗产品商业化落地也需要“东风”加持。觅瑞的胃癌检测产品正好赶上国内癌症筛查政策升级，被列入了《常见恶性肿瘤联合筛查专家共识》。今年5月在港交所的成功上市，更给这个红利加动力。觅瑞招股书显示，其募资净额中51%将直接用于GASTROClear™的国内监管备案与商业化推进，这种政策机遇与资本助力的双重加持，说不定能让国内精准早筛技术的普及节奏加快。
  382 评论
  1
  分享
  举报
- 股海蓝天股海蓝天
  ·2025-07-31
  现在这个时代，国际化布局是企业发展很重要的一环。作为在新加坡成立并在香港上市的企业，觅瑞展现出了全球化的视野，觅瑞的胃癌早筛产品GASTROClear™已经成功获得了欧盟CE和美国FDA认证。这种国际化认证不仅验证了产品的技术可靠性，也为开拓全球更大的市场奠定了基础。
  917 评论
  2
  分享
  举报
- 股海蓝天股海蓝天
  ·2025-07-16
  港股医疗创新板块的竞争格局是越来越清晰了，特别是具备技术迭代能力的企业，核心竞争力强。政策鼓励医疗技术创新，资本对拥有梯度产品线的企业关注度更高。像觅瑞这一类技术超前的企业，长期竞争力慢慢凸显了，都排着队上市
  726 评论
  2
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4214972246749820","uuid":"4214972246749820","gmtCreate":1751869059340,"gmtModify":1751875012765,"name":"股海蓝天","pinyin":"ghltguhailantian","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/59436dc25a0c427f9500be9b0d23c3d6","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":507077223723648,"gmtCreate":1764828756070,"gmtModify":1764829888231,"author":{"id":"4214972246749820","authorId":"4214972246749820","name":"股海蓝天","avatar":"https://static.tigerbbs.com/59436dc25a0c427f9500be9b0d23c3d6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214972246749820","idStr":"4214972246749820"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。","text":"$MIRXES-B(02629)$ 现在全球顶尖的癌症早筛公司，都在抢着扩大市场份额。核心技术突破与权威认证是企业打开局面的入场券。觅瑞的觅小卫最近国内获批，而且之前已经有欧盟CE认证和美国FDA突破性医疗器械认证，技术硬、口碑好，未来发展潜力巨大。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/507077223723648","isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":482307821728632,"gmtCreate":1758779883781,"gmtModify":1758781842803,"author":{"id":"4214972246749820","authorId":"4214972246749820","name":"股海蓝天","avatar":"https://static.tigerbbs.com/59436dc25a0c427f9500be9b0d23c3d6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214972246749820","idStr":"4214972246749820"},"themes":[],"htmlText":"医疗产品商业化落地也需要“东风”加持。觅瑞的胃癌检测产品正好赶上国内癌症筛查政策升级，被列入了《常见恶性肿瘤联合筛查专家共识》。今年5月在港交所的成功上市，更给这个红利加动力。觅瑞招股书显示，其募资净额中51%将直接用于GASTROClear™的国内监管备案与商业化推进，这种政策机遇与资本助力的双重加持，说不定能让国内精准早筛技术的普及节奏加快。","listText":"医疗产品商业化落地也需要“东风”加持。觅瑞的胃癌检测产品正好赶上国内癌症筛查政策升级，被列入了《常见恶性肿瘤联合筛查专家共识》。今年5月在港交所的成功上市，更给这个红利加动力。觅瑞招股书显示，其募资净额中51%将直接用于GASTROClear™的国内监管备案与商业化推进，这种政策机遇与资本助力的双重加持，说不定能让国内精准早筛技术的普及节奏加快。","text":"医疗产品商业化落地也需要“东风”加持。觅瑞的胃癌检测产品正好赶上国内癌症筛查政策升级，被列入了《常见恶性肿瘤联合筛查专家共识》。今年5月在港交所的成功上市，更给这个红利加动力。觅瑞招股书显示，其募资净额中51%将直接用于GASTROClear™的国内监管备案与商业化推进，这种政策机遇与资本助力的双重加持，说不定能让国内精准早筛技术的普及节奏加快。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/482307821728632","isVote":1,"tweetType":1,"viewCount":382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":462461216379344,"gmtCreate":1753924479813,"gmtModify":1753925504061,"author":{"id":"4214972246749820","authorId":"4214972246749820","name":"股海蓝天","avatar":"https://static.tigerbbs.com/59436dc25a0c427f9500be9b0d23c3d6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214972246749820","idStr":"4214972246749820"},"themes":[],"htmlText":"现在这个时代，国际化布局是企业发展很重要的一环。作为在新加坡成立并在香港上市的企业，觅瑞展现出了全球化的视野，觅瑞的胃癌早筛产品GASTROClear™已经成功获得了欧盟CE和美国FDA认证。这种国际化认证不仅验证了产品的技术可靠性，也为开拓全球更大的市场奠定了基础。","listText":"现在这个时代，国际化布局是企业发展很重要的一环。作为在新加坡成立并在香港上市的企业，觅瑞展现出了全球化的视野，觅瑞的胃癌早筛产品GASTROClear™已经成功获得了欧盟CE和美国FDA认证。这种国际化认证不仅验证了产品的技术可靠性，也为开拓全球更大的市场奠定了基础。","text":"现在这个时代，国际化布局是企业发展很重要的一环。作为在新加坡成立并在香港上市的企业，觅瑞展现出了全球化的视野，觅瑞的胃癌早筛产品GASTROClear™已经成功获得了欧盟CE和美国FDA认证。这种国际化认证不仅验证了产品的技术可靠性，也为开拓全球更大的市场奠定了基础。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/462461216379344","isVote":1,"tweetType":1,"viewCount":917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":457090171601064,"gmtCreate":1752631426816,"gmtModify":1752632495897,"author":{"id":"4214972246749820","authorId":"4214972246749820","name":"股海蓝天","avatar":"https://static.tigerbbs.com/59436dc25a0c427f9500be9b0d23c3d6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4214972246749820","idStr":"4214972246749820"},"themes":[],"htmlText":"港股医疗创新板块的竞争格局是越来越清晰了，特别是具备技术迭代能力的企业，核心竞争力强。政策鼓励医疗技术创新，资本对拥有梯度产品线的企业关注度更高。像觅瑞这一类技术超前的企业，长期竞争力慢慢凸显了，都排着队上市","listText":"港股医疗创新板块的竞争格局是越来越清晰了，特别是具备技术迭代能力的企业，核心竞争力强。政策鼓励医疗技术创新，资本对拥有梯度产品线的企业关注度更高。像觅瑞这一类技术超前的企业，长期竞争力慢慢凸显了，都排着队上市","text":"港股医疗创新板块的竞争格局是越来越清晰了，特别是具备技术迭代能力的企业，核心竞争力强。政策鼓励医疗技术创新，资本对拥有梯度产品线的企业关注度更高。像觅瑞这一类技术超前的企业，长期竞争力慢慢凸显了，都排着队上市","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/457090171601064","isVote":1,"tweetType":1,"viewCount":726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}